Barriers to Overcome in Lupus Drug Development

 - Written by GlobalData immunology and neurology analyst, Dina Rufo.

It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year old, Benlysta (belimumab) is the first human monoclonal antibody for the treatment of lupus. There are four main types of lupus: neonatal, discoid (DLE), drug-induced (DIL), and systemic lupus erythmatosus (SLE). When lupus is discussed, most often times it is in reference to SLE as it affects the majority of patients.